Scientists Created a 'Universal' Kidney To Match Any Blood Type

After several years of hard work, researchers are closer than ever to a key breakthrough in kidney transplants: being able to transfer kidneys from donors with different blood types than the recipients, which could significantly speed up waiting times and save lives.

In research published last year, a team from institutions across Canada and China reported creating a 'universal' kidney that, in theory, can be accepted by any patient.

Their test organ survived and functioned for several days in the body of a brain-dead recipient, whose family consented to the research.

People with type O blood who need a kidney usually have to wait for a type O kidney to become available from a donor. That accounts for more than half the people on waitlists, but because type O kidneys can function in people with other blood types, they're in short supply.

While it is currently possible to transplant kidneys of different blood types, by training the recipient's body not to reject the organ, the existing process is far from perfect and not particularly practical.

It's time-consuming, expensive, and risky, and it also requires living donors to work, as the recipient needs time to be prepped.

Blood type (or blood group) is determined, in part, by the ABO blood group antigens present on red blood cells. Antibodies in our blood plasma detect when a foreign antigen marker is present (InvictaHOG/Public Domain/Wikimedia Commons)

In the new research, the researchers effectively converted a type A kidney into a type O kidney, using special, previously identified enzymes that strip away the sugar molecules (antigens) acting as markers of type A blood.
The researchers compare the enzymes to scissors working on the molecular scale: By snipping off part of the type A antigen chains, they can be turned into the ABO antigen-free status that characterizes type O blood.
Once that's done, the immune system no longer sees the organ as foreign.
There remain many challenges ahead before trials in humans can be considered.

The transplanted kidney did start to show signs of type A blood again by the third day, which led to an immune response – but the response was less severe than would usually be expected, and there were signs that the body was trying to tolerate the kidney.

Source: Enzyme-converted O kidneys allow ABO-incompatible transplantation w...